MRK
Merck & Co., Inc.
- Research and development, 2025
- $15.8B
- YoY, 2025
- −12.0%
- 5-year CAGR
- +3.3%
- 10-year CAGR
- +8.9%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $15.8B | −12.0% |
| 2024 | $17.9B | −41.2% |
| 2023 | $30.5B | +125.4% |
| 2022 | $13.5B | +10.6% |
| 2021 | $12.2B | −8.6% |
| 2020 | $13.4B | +37.8% |
| 2019 | $9.7B | −0.3% |
| 2018 | $9.8B | −5.7% |
| 2017 | $10.3B | +0.8% |
| 2016 | $10.3B | +53.1% |
| 2015 | $6.7B | −6.6% |
| 2014 | $7.2B | −4.3% |
| 2013 | $7.5B | −8.1% |
| 2012 | $8.2B | −3.5% |
| 2011 | $8.5B | −23.8% |
| 2010 | $11.1B | +90.1% |
| 2009 | $5.8B | +21.6% |
| 2008 | $4.8B | −1.6% |
| 2007 | $4.9B | — |